HIV Prevention

;

USPSTF updates PrEP rating to include long-acting PrEP to prevent HIV

Dec 13, 2022

The HIV+Hepatitis Policy Institute is extremely pleased that the USPSTF, at our request, has updated its recommendation for PrEP to prevent HIV and include newly approved long-acting drugs. Due to the importance of preventing HIV and the superiority of long-acting PrEP compared to daily oral PrEP, the USPSTF acted in record speed. Now we urge insurers to ensure its coverage and offer it without cost-sharing.  We are hearing many complaints by people who are still being charged cost-sharing for oral PrEP and its associated services. People seeking PrEP are facing too many barriers to access and we need state and federal regulators to take the necessary steps to correct these problems.

read more

Texas court decision on PrEP must not stand: Preventing HIV is a public health imperative

Sep 7, 2022

Preventive services covered by private insurance plans without cost- sharing, such as HIV testing, hepatitis B and C testing, and PrEP, are all critical and well-established public health preventive services that must continue. To single out PrEP, which are FDA approved drugs that effectively prevent HIV, and conclude that its coverage violates the religious freedom of certain individuals, is plain wrong, highly discriminatory, and impedes the public health of our nation.  PrEP is not just for gay men, but for anyone who may be at risk of HIV.

read more

Senate Appropriations leadership proposes significant increases for domestic HIV programs

Jul 28, 2022

The leadership of the United States Senate Appropriations Committee is proposing to significantly increase funding to continue to ramp up efforts to end HIV in the United States.  The Senate bills include increased funding for the Ending the HIV Epidemic in the U.S. initiative by at least $240 million for domestic HIV testing, prevention, treatment, and research programs. While it is not as much as proposed in President Biden’s budget, in some instances it is more than what was proposed by the House.

read more

House proposes funding increases for domestic HIV programs

Jun 23, 2022

The U.S. House of Representatives Labor, HHS Appropriations Subcommittee is proposing to increase funding to continue to ramp up efforts to end HIV in the United States. However, it fails to include a national program to increase access to PrEP, which are medications that prevent HIV.  In addition to an increase of $225 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic initiative, the FY23 Labor, HHS appropriations bill is proposing a $75 million increase to the Ryan White HIV/AIDS Program and $200 million more for NIH AIDS Research.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest